ONS Journal Activity 2017: BRAF/MEK 
Inhibitor Therapy: Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events and Potential Drug Interactions

ONS Journal Activity 2017: BRAF/MEK 
Inhibitor Therapy: Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events and Potential Drug Interactions

Contact hours
0.50
Next start date
None Available

This educational activity is based upon a peer-reviewed article published in the August 2017 Clinical Journal of Oncology Nursing Supplement. To receive CNE credit for this activity you must

  • Read the entire article
  • Submit an evaluation through the link listed in the article.

As an exclusive benefit to ONS members, this is a free CNE activity. For nonmembers, please note that article access includes a fee.

 

ILNA Breakdown

OCN®

0.5 ILNA points may be applied toward:

  • 0.5 points: Symptom Management 

AOCNP® and AOCNS®

0.5 ILNA points may be applied toward:

  • 0.5 points: Side Effect and Symptom Management 

The Oncology Nursing Society is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.

ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850.

How to Sign Up
1 Log In
2 No sessions available

Menu